Can you provide the average price target for MAREX GROUP PLC stock?
11 analysts have analysed MRX and the average price target is 53.04 USD. This implies a price increase of 6.12% is expected in the next year compared to the current price of 49.98.
NASDAQ:MRX • GB00BMT7GT62
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MAREX GROUP PLC (MRX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-08 | Keefe, Bruyette & Woods | Reiterate | Outperform -> Outperform |
| 2026-04-02 | UBS | Maintains | Buy -> Buy |
| 2026-03-27 | TD Cowen | Maintains | Buy -> Buy |
| 2026-03-27 | Barclays | Maintains | Overweight -> Overweight |
| 2026-03-04 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-14 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-08 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-12 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-07 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-08 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-14 | Barclays | Maintains | Overweight -> Overweight |
| 2025-06-09 | Barclays | Maintains | Overweight -> Overweight |
| 2025-05-16 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-05-16 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-04-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-03 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-03-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-03-07 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-01-13 | Barclays | Maintains | Overweight -> Overweight |
| 2025-01-07 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-12-20 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2024-12-09 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-21 | HSBC | Initiate | Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.761B 79.48% | 2.13B 20.97% | 2.717B 27.58% | 2.377B -12.51% | 2.572B 8.20% | 2.885B 12.17% | |
| EBITDA YoY % growth | -359.6M -359.85% | -434.1M -20.72% | N/A 194.77% | 455.84M 10.80% | 529.27M 16.11% | N/A | |
| EBIT YoY % growth | -381.5M -314.67% | -462.9M -21.34% | -512.2M -10.65% | 475.16M 192.77% | 535.61M 12.72% | N/A | |
| Operating Margin | -21.67% | -21.74% | -18.85% | 19.99% | 20.82% | N/A | |
| EPS YoY % growth | N/A | N/A | 4.02 33.71% | 4.29 6.77% | 4.83 12.42% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.35 48.50% | 1.17 14.68% | 1.16 20.50% | 1.27 12.07% | 1.23 -8.92% | 1.27 8.59% | 1.33 14.55% | 1.37 8.36% |
| Revenue Q2Q % growth | 661.45M 41.55% | 573.29M 14.64% | 562.45M 16.06% | 614.23M 7.36% | 643.77M -2.67% | 667.61M 16.45% | 640.04M 13.80% | 701.34M 14.18% |
| EBITDA Q2Q % growth | 155.98M 52.65% | 121.43M 218.35% | 116.31M 7.69% | 135M 11.51% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 139.29M 232.78% | 117.78M 198.89% | 116.4M 180.44% | 127.88M 50.09% | 134.73M -3.27% | 137.87M 17.06% | 132.01M 13.41% | 144.83M 13.25% |
All data in USD
11 analysts have analysed MRX and the average price target is 53.04 USD. This implies a price increase of 6.12% is expected in the next year compared to the current price of 49.98.
MAREX GROUP PLC (MRX) will report earnings on 2026-05-13.
The consensus EPS estimate for the next earnings of MAREX GROUP PLC (MRX) is 1.35 USD and the consensus revenue estimate is 661.45M USD.
The expected long term growth rate for MAREX GROUP PLC (MRX) is 14.06%.